BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18798516)

  • 1. [Preparation and dissolution in vitro of esomeprazole zinc solid dispersion].
    Xie P; Xie YM; Song H; Song X; Zuo YJ; Qiu Y; Tang XH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):648-50. PubMed ID: 18798516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics.
    Xie Y; Xie P; Song X; Tang X; Song H
    Int J Pharm; 2008 Aug; 360(1-2):53-7. PubMed ID: 18495389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of fast dissolving flurbiprofen and esomeprazole solid dispersion using spray drying technique.
    Pradhan R; Tran TH; Kim SY; Woo KB; Choi YJ; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2016 Apr; 502(1-2):38-46. PubMed ID: 26899979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
    Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
    Gorajana A; Kit WW; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different carriers on in vitro dissolution behavior and physicochemical characterization of glycyrrhetinic acid solid dispersions.
    Qian J; Li F; Zhang C; Chai S; Liu T; Sui X
    Pak J Pharm Sci; 2022 Nov; 35(6):1539-1548. PubMed ID: 36789813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
    Samy AM; Marzouk MA; Ammar AA; Ahmed MK
    Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.
    Dos Santos KM; Barbosa RM; Vargas FGA; de Azevedo EP; Lins ACDS; Camara CA; Aragão CFS; Moura TFLE; Raffin FN
    Drug Dev Ind Pharm; 2018 May; 44(5):750-756. PubMed ID: 29206496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and in vitro study of buagafuran solid dispersions].
    Xia XJ; Tao ZH; Ren Y; Wang RY; Liu YL
    Yao Xue Xue Bao; 2008 May; 43(5):548-52. PubMed ID: 18717346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
    Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
    Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.
    Yadav PS; Kumar V; Singh UP; Bhat HR; Mazumder B
    Saudi Pharm J; 2013 Jan; 21(1):77-84. PubMed ID: 24109206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of solid dispersions of carvedilol with PVP K30.
    Sharma A; Jain CP
    Res Pharm Sci; 2010 Jan; 5(1):49-56. PubMed ID: 21589768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.